Kayog, Tayanor K.

HRN: 22-49-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
CEFUROXIME 1.5GM (VIAL)
08/06/2024
08/07/2024
IVT
1.5g
Q8hrs X 3doses
Post CS With IUD
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: